InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-05-15 | Rob Bresnahan(R-PA08) | house | Purchase | $1,001 - $15,000 |
| 2025-05-12 | Jefferson Shreve(R-IN06) | house | Sale | $15,001 - $50,000 |
| 2025-05-08 | Jefferson Shreve(R-IN06) | house | Purchase | $15,001 - $50,000 |
| 2025-04-08 | Rob Bresnahan(R-PA08) | house | Sale | $1,001 - $15,000 |
| 2025-04-07 | Jefferson Shreve(R-IN06) | house | Sale | $15,001 - $50,000 |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $4.66B+15.6% | $4.03B+11.3% | $3.62B+24.5% | $2.91B+18.8% | $2.45B |
| Cost of sales | $1.86B+16.6% | $1.59B+19.6% | $1.33B+29.9% | $1.03B+33.7% | $768.0M |
| Gross profit | $2.80B+14.9% | $2.44B+6.5% | $2.29B+21.5% | $1.88B+12.1% | $1.68B |
| Research and development | $599.1M+8.5% | $552.4M+9.2% | $505.8M+4.5% | $484.2M-6.4% | $517.1M |
| Selling, general and administrative | $1.29B+0.4% | $1.29B+8.5% | $1.19B+17.6% | $1.01B+24.3% | $810.5M |
| Total operating expenses | $1.89B+2.8% | $1.84B+8.7% | $1.69B+13.4% | $1.49B+5.5% | $1.41B |
| Operating income | $911.8M+52.0% | $600.0M+0.4% | $597.7M+52.8% | $391.2M+47.2% | $265.8M |
| Other income, net | $176.6M+62.0% | $109.0M-3.3% | $112.7M | — | — |
| Income before income taxes | $1.09B+53.5% | $709.0M-0.2% | $710.4M+81.8% | $390.8M+52.2% | $256.8M |
| Income tax expense | $252.1M+89.8% | $132.8M-21.4% | $168.9M+240.5% | $49.6M+24.3% | $39.9M |
| Net income | $836.3M+45.1% | $576.2M+6.4% | $541.5M+58.7% | $341.2M+57.3% | $216.9M |
| Basic net income per share (in usd per share) | $2.1M+46.6% | $1.5M+4.3% | $1.4M+59.1% | $880K+57.1% | $560K |
| Shares used to compute basic net income per share (in shares) | $390.2M-0.9% | $393.6M+2.0% | $386.0M-0.9% | $389.4M+0.6% | $386.9M |
| Diluted net income per share (in usd per share) | $2.1M+47.2% | $1.4M+9.2% | $1.3M+58.5% | $820K+54.7% | $530K |
| Shares used to compute diluted net income per share (in shares) | $405.5M-1.7% | $412.7M-3.0% | $425.5M-0.5% | $427.5M-0.3% | $428.8M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Should DexCom’s Margin Gains and Expanded Coverage Require Action From DexCom (DXCM) Investors?
Healthcare earnings impress with 86% beat rate, yet sector lags: Earnings Scorecard
DXCM Q1 Deep Dive: U.S. Growth Moderates as Product Momentum and Coverage Expansion Drive Strategy
DexCom Medicare Coverage NCD Remains Biggest 2026 Catalyst, RBC Says